Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132467) titled 'A real-world study of first-line maintenance therapy with senaparib in newly diagnosed advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer' on Sept. 15.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: JIANGSU CANCER HOSPITAL
Condition:
Advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-15
Target Sample Size: Observation Group:52;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=335748
Pu...